tiprankstipranks

Robert Van-Nostrand Insider Profile

4 Followers
Robert Van-Nostrand, Director at Intra-Cellular Therapies, holds 7.57K shares in Intra-Cellular Therapies (Ticker: ITCI), holds ― shares in SELLAS Life Sciences Group (Ticker: SLS), holds 0.00 shares in Achillion Pharmaceuticals (Ticker: ACHN).
tipranks
Robert Van-Nostrand

Robert Van-Nostrand
Intra-Cellular Therapies (ITCI)
Director

Ranked #10,658 out of 78,624 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+32.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$407K
53.50%
46.50%
0.00%
A breakdown of Robert Van-Nostrand's holdings

Insider Roles

Yield10 Bioscience
(YTEN)
Director
Intra-Cellular Therapies
(ITCI)
Director
SELLAS Life Sciences Group
(SLS)
Director
Roles that Robert Van-Nostrand holds in companies

Most Profitable Insider Trade

Stock:
Achillion Pharmaceuticals
(ACHN)
Rating:Informative Buy
Date:Dec 18, 2018 - Dec 18, 2019
Return:+216.90%
The most profitable trade made by Robert Van-Nostrand

Robert Van-Nostrand's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Jul 02, 2020
Director
Uninformative Buy
7.06K
$189.02K
SELLAS Life Sciences Group
Director
Yield10 Bioscience
Jul 05, 2017
Director
Uninformative Buy
$217.50K
ACHN
Achillion Pharmaceuticals
Jan 29, 2020
Uninformative Sell
252.00K
$0.00
ENUMQ
Enumeral Biomedical
Jan 05, 2017
Uninformative Buy
$45.45
List of latest transactions for each holding click on a transaction to see Robert Van-Nostrand's performance on stock

Robert Van-Nostrand insider profile FAQ

What is the percentage of profitable transactions made by Robert Van-Nostrand?
The percentage of profitable transactions made by Robert Van-Nostrand is 40%.
    What is the average return per transaction made by Robert Van-Nostrand?
    The average return per transaction made by Robert Van-Nostrand is 32.30%.
      What stocks does Robert Van-Nostrand hold?
      Robert Van-Nostrand holds: ITCI, SLS, YTEN, ACHN, ENUMQ stocks.
        What was Robert Van-Nostrand’s latest transaction?
        Robert Van-Nostrand latest transaction was an Uninformative Buy of $7.06K.
          What was Robert Van-Nostrand's most profitable transaction?
          Robert Van-Nostrand’s most profitable transaction was an Informative Buy of ACHN stock on December 18, 2018. The return on the trade was 216.90%.
            What is Robert Van-Nostrand's role in Intra-Cellular Therapies?
            Robert Van-Nostrand's role in Intra-Cellular Therapies is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.